Almost half of all the corporate self-funded research and development in the US is being conducted in five states, according to a new analysis by the National Science Foundation.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: genomic analysis of Malaysian tuberculosis strain, database of bat genomes, and more.
An editorial appearing at The Scientist bemoans the high numbers of mitochondrial genome papers and suggests a different path for mitochondrial genome research.
Researchers and drug developers are excited about the potential of CRISPR-Cas9-based therapeutics, the Wall Street Journal reports.
US lawmakers want to develop a new incarnation of the National Children's Study, ScienceInsider reports.